Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
ZoomInfo Announces First Quarter 2025 Financial Results
-
Tyra Biosciences to Participate at Upcoming Investor Conferences
-
Simon® Reports First Quarter 2025 Results and Reaffirms Full Year 2025 Real Estate FFO Per Share Guidance
-
Deckers Brands Announces Conference Call to Review Fourth Quarter and Full Fiscal Year 2025 Earnings Results
-
Terreno Realty Corporation Announces Lease in Woodinville, WA
-
Nuvation Bio to Participate in Upcoming Investor Conferences
-
AlTi Global, Inc. Reports First Quarter 2025 Financial Results
-
FiscalNote Reports First Quarter 2025 Financial Results
-
Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights
-
Savara Announces Participation in the H.C. Wainwright & Co. 3rd Annual BioConnect Investor Conference
-
Magnachip Reports Results for First Quarter 2025
-
Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments
-
Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Archer Announces First Quarter Results, Highlighting On-Track UAE Launch & New “Launch Edition” Customers
-
QIAGEN enhances leading clinical genomics portfolio with acquisition of Genoox AI-powered software
-
Axos Financial, Inc. Announces $100 Million Increase to Stock Repurchase Program
-
China Liberal Education Holdings Limited Receives Staff Determination Notice from Nasdaq and Plans to Appeal
-
Gaia Reports First Quarter 2025 Results
-
Phunware Reports First Quarter 2025 Financial Results
-
Virtus Investment Partners Reports Preliminary April 30, 2025 Assets Under Management
-
Viasat Announces Appointments of Bill LaPlante and Michael Paull to Its Board of Directors
-
SKYX Announces Corporate Update Call Including New Developments
-
Rapid7 Announces First Quarter 2025 Financial Results
-
REPAY Board of Directors Authorizes Increase to Share Repurchase Program, Up to $75 million
-
Alight to Participate in the J.P. Morgan Global Technology, Media and Communications Conference
-
Akoya Biosciences Reports First Quarter 2025 Financial Results
-
Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
-
HF Foods Reports First Quarter 2025 Financial Results
-
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for AVMAPKI™FAKZYNJA™ CO-PACK
-
OptimizeRx Reports First Quarter 2025 Financial Results and Updates Fiscal Year 2025 Guidance
-
Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference
-
Vir Biotechnology to Participate in Bank of America Securities 2025 Healthcare Conference
-
LifeMD to Participate in Three Investor Conferences During May
-
Amplify Energy Announces First Quarter 2025 Results, Beta Development Update and Updated Full-Year 2025 Guidance
-
Carbon Revolution Secures Further Release of $5m Million from OIC and further $0.4 Million Reserve Release from Existing Lenders
-
GigaCloud Technology Inc Announces First Quarter Ended March 31, 2025 Financial Results
-
Hour Loop Reports First Quarter of 2025 Results
-
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TPI Composites, Inc. Announces First Quarter 2025 Earnings Results – Operational Execution and Strategic Initiatives Drive Improved Financial Results; Initiation of Strategic Review
-
FibroGen Reports First Quarter 2025 Financial Results and Provides Business Update
-
BLINK CHARGING ANNOUNCES FIRST QUARTER 2025 RESULTS
-
Canadian Securities Exchange Welcomes Listing of Strathmore Plus Uranium Corp.
-
CODI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Compass Diversified Holdings Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
The Nike NFTs INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Nike-themed non-fungible tokens ("NFTs") Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
NSSC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that NAPCO Security Technologies, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CAR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Avis Budget Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ZBIO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
CERE INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cerevel Therapeutics Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

